CL2017002086A1 - Composición hemostática y dispositivo hemostático (variantes) - Google Patents

Composición hemostática y dispositivo hemostático (variantes)

Info

Publication number
CL2017002086A1
CL2017002086A1 CL2017002086A CL2017002086A CL2017002086A1 CL 2017002086 A1 CL2017002086 A1 CL 2017002086A1 CL 2017002086 A CL2017002086 A CL 2017002086A CL 2017002086 A CL2017002086 A CL 2017002086A CL 2017002086 A1 CL2017002086 A1 CL 2017002086A1
Authority
CL
Chile
Prior art keywords
hemostatic
composition
variants
agents
hemostatic device
Prior art date
Application number
CL2017002086A
Other languages
English (en)
Inventor
Petro Andriyovych Manoryk
Vadym Borysovych Mazevych
Igor Sergiyovych Tsurupa
Ihor Volodymyrovych Gaiovych
Svitlana Oleksandrivna Sotnik
Volodimir Mykolayovych Granich
Iaroslav Viktorovych Kyshenia
Original Assignee
Petro Andriyovych Manoryk
Vadym Borysovych Mazevych
Igor Sergiyovych Tsurupa
Ihor Volodymyrovych Gaiovych
Svitlana Oleksandrivna Sotnik
Volodimir Mykolayovych Granich
Iaroslav Viktorovych Kyshenia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from UAA201501285A external-priority patent/UA115667C2/uk
Priority claimed from UAU201501288U external-priority patent/UA101868U/uk
Application filed by Petro Andriyovych Manoryk, Vadym Borysovych Mazevych, Igor Sergiyovych Tsurupa, Ihor Volodymyrovych Gaiovych, Svitlana Oleksandrivna Sotnik, Volodimir Mykolayovych Granich, Iaroslav Viktorovych Kyshenia filed Critical Petro Andriyovych Manoryk
Publication of CL2017002086A1 publication Critical patent/CL2017002086A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/54—Radio-opaque materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

<p>La composición hemostática, que comprende retención de agua, supresión de polvo aglutinante, agentes hemostáticos inorgánicos y orgánicos, y dispositivo hemostático comprende la composición de agentes hemostáticos y un recipiente que mantiene la composición hemostática.</p>
CL2017002086A 2015-02-16 2017-08-15 Composición hemostática y dispositivo hemostático (variantes) CL2017002086A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UAA201501285A UA115667C2 (uk) 2015-02-16 2015-02-16 Гемостатична композиція та гемостатичний засіб (варіанти)
UAU201501288U UA101868U (xx) 2015-02-16 2015-02-16 Гемостатична композиція

Publications (1)

Publication Number Publication Date
CL2017002086A1 true CL2017002086A1 (es) 2018-03-16

Family

ID=55809163

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017002086A CL2017002086A1 (es) 2015-02-16 2017-08-15 Composición hemostática y dispositivo hemostático (variantes)

Country Status (23)

Country Link
US (1) US20180236123A1 (es)
EP (1) EP3258974A1 (es)
JP (1) JP2018506410A (es)
KR (1) KR20170118198A (es)
CN (1) CN107454851A (es)
AU (1) AU2016220560A1 (es)
BR (1) BR112017017457A2 (es)
CA (1) CA2975464A1 (es)
CL (1) CL2017002086A1 (es)
CO (1) CO2017008219A2 (es)
CR (1) CR20170379A (es)
CU (1) CU20170107A7 (es)
DO (1) DOP2017000192A (es)
EA (1) EA201791857A1 (es)
IL (1) IL254012A0 (es)
MX (1) MX2017010458A (es)
NI (1) NI201700103A (es)
PE (1) PE20180230A1 (es)
PH (1) PH12017501490A1 (es)
SG (1) SG11201706720WA (es)
TN (1) TN2017000345A1 (es)
WO (1) WO2016133483A1 (es)
ZA (1) ZA201706256B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
CN107789022B (zh) * 2016-08-31 2019-12-20 王洛 链式快速止血装置
US11504341B2 (en) 2016-10-27 2022-11-22 Egy-Nano Pharma, Lp Nanotechnology-based hemostatic dressings
US10583216B2 (en) * 2016-12-20 2020-03-10 Shilpa Medicare Limited Scaffold compositions for tissue repair
CN107213508B (zh) * 2017-06-09 2018-04-06 中南大学 一种含铁氧化物/纳米高岭土复合止血剂及其制备方法
KR102368895B1 (ko) 2017-08-23 2022-03-02 코오롱인더스트리 주식회사 접착제 조성물, 이를 포함하는 접착제 및 이의 제조방법
EP3725925B1 (en) * 2017-12-15 2022-09-21 Toray Industries, Inc. Woven fabric and method for manufacturing same
CN108294797B (zh) * 2018-01-03 2019-09-03 王洛 快速止血装置的制造方法
CN108030529B (zh) * 2018-01-03 2020-06-19 王洛 带气囊的快速止血装置
CN108294798B (zh) * 2018-01-03 2020-09-25 王洛 带导丝的快速止血装置
BE1025996A9 (fr) 2018-01-19 2020-05-11 Hyloris Dev Sa Solution orale d’acide tranexamique
WO2020026209A1 (en) * 2018-08-03 2020-02-06 Anne's Day Limited Absorbent tampon for treatment of menstrual symptoms
CN109172857A (zh) * 2018-09-10 2019-01-11 中国药科大学 一种外创用复合止血材料及其制备方法
IL262716A (en) 2018-11-01 2018-11-29 Omrix Biopharmaceuticals Ltd Oxidized cellulose preparations
CN111249516B (zh) * 2018-12-01 2020-12-22 浙江大学 一种含胰蛋白酶的止血织物及其制备方法
CN109620999A (zh) * 2019-01-12 2019-04-16 王若梅 一种复合止血医用组织胶的制备方法
CN113382755A (zh) * 2019-01-28 2021-09-10 希普罗特克有限公司 具有促凝血特性、免疫调节特性和组织再生特性的抗微生物组合物
JP7389418B2 (ja) * 2019-02-18 2023-11-30 青葉化成株式会社 止血剤
CN111714683B (zh) * 2019-03-19 2023-04-18 陕西佰傲再生医学有限公司 一种骨止血材料及其制备方法
CN111714687A (zh) * 2019-03-19 2020-09-29 广东博与再生医学有限公司 一种骨止血材料及其制备方法
KR102366423B1 (ko) * 2019-03-20 2022-02-22 한남대학교 산학협력단 대량 출혈을 신속하게 제어할 수 있는 생분해성 고분자를 용액방사에 적용한 지혈 시스템
KR102220182B1 (ko) * 2019-09-02 2021-02-25 김형훈 관절경 출혈 컨트롤장치
US20210106717A1 (en) * 2019-10-10 2021-04-15 Cook Medical Technologies Llc Bonded powders for the treatment of bodily lesions
CN110721334B (zh) * 2019-11-26 2021-02-02 中南大学湘雅二医院 一种止血创伤敷料及其制备方法
FR3105501B1 (fr) 2019-12-24 2022-07-29 Atos Integration Système d’assistant personnel vocal pour une gestion de dialogue avec une application d’invitations exécutables
KR102302405B1 (ko) * 2020-01-07 2021-09-16 주식회사 테라시온 바이오메디칼 마이크로-비드 및 그 제조방법, 이를 포함하는 지혈 드레싱의 제조방법
US11654057B2 (en) 2020-04-09 2023-05-23 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same
KR20220009198A (ko) * 2020-07-15 2022-01-24 이시우 비강 패킹 구조체
CN112472416A (zh) * 2020-11-24 2021-03-12 天长市康特美防护用品有限公司 一种一次性吸血腋垫
CN114796592B (zh) * 2021-01-21 2023-09-08 重庆理工大学 一种壳聚糖基抑菌凝胶剂的制备方法
US20220323634A1 (en) * 2021-04-06 2022-10-13 The United States Of America, As Represented By The Secretary Of Agriculture Fabric compositions comprising attached zeolite and/or a zeolite/pectin complex
CN113144277B (zh) * 2021-04-13 2022-06-14 武汉理工大学 一种可注射流体明胶及其制备方法和应用
CN113425889B (zh) * 2021-06-25 2023-01-24 延安大学 一种抗菌止血海绵及其制备方法和应用
CN113520627B (zh) * 2021-07-23 2022-10-18 亚都控股集团有限公司 一种能够被多重智能识别的医用棉纱垫或纱布叠片及其制备方法
KR102630826B1 (ko) * 2021-10-18 2024-01-29 주식회사 파인메딕스 지혈제 분사기
CN114045587B (zh) * 2021-11-10 2022-09-02 武汉纺织大学 基于亲水改性壳聚糖的复合纱线止血材料
CN114343974A (zh) * 2022-01-08 2022-04-15 良药控股集团江苏医疗用品有限公司 一种预防新创伤疤痕形成医用水凝抗菌敷料
US11642324B1 (en) 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof
CN114805555A (zh) * 2022-04-12 2022-07-29 湖南农业大学 一种从血浆中提取免疫球蛋白IgG的方法
CN115721775B (zh) * 2022-12-09 2023-09-29 海南苏生生物科技有限公司 一种复合改性生物水凝胶敷料及其制备工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027327A1 (en) * 1998-11-12 2000-05-18 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
CN101160143A (zh) * 2005-02-15 2008-04-09 弗吉尼亚大学 用于急性止血、治疗急性损伤和慢性溃疡的矿物技术（mt）
US20070154509A1 (en) * 2005-12-30 2007-07-05 Wilcher Steve A Adsorbent-Containing Hemostatic Devices
US8202532B2 (en) 2006-05-26 2012-06-19 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7968114B2 (en) 2006-05-26 2011-06-28 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
US7604819B2 (en) * 2006-05-26 2009-10-20 Z-Medica Corporation Clay-based hemostatic agents and devices for the delivery thereof
DE102008005469A1 (de) * 2008-01-21 2009-07-23 Kettenbach Gmbh & Co. Kg Pastöses Einsetzmaterial zur Erweiterung des Zahnfleischsulcus und dessen Verwendung
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
IN2014DN11041A (es) * 2012-06-22 2015-09-25 Z Medica Llc

Also Published As

Publication number Publication date
AU2016220560A8 (en) 2017-09-28
BR112017017457A2 (pt) 2018-04-10
AU2016220560A1 (en) 2017-09-21
WO2016133483A1 (en) 2016-08-25
CU20170107A7 (es) 2018-07-05
PH12017501490A1 (en) 2018-01-29
CO2017008219A2 (es) 2018-01-05
EP3258974A1 (en) 2017-12-27
ZA201706256B (en) 2019-02-27
US20180236123A1 (en) 2018-08-23
IL254012A0 (en) 2017-10-31
KR20170118198A (ko) 2017-10-24
PE20180230A1 (es) 2018-01-31
JP2018506410A (ja) 2018-03-08
CR20170379A (es) 2018-01-25
TN2017000345A1 (en) 2019-01-16
CA2975464A1 (en) 2016-08-25
SG11201706720WA (en) 2017-09-28
NI201700103A (es) 2017-09-11
DOP2017000192A (es) 2017-11-15
MX2017010458A (es) 2018-04-24
CN107454851A (zh) 2017-12-08
EA201791857A1 (ru) 2018-02-28

Similar Documents

Publication Publication Date Title
CL2017002086A1 (es) Composición hemostática y dispositivo hemostático (variantes)
CL2016002772A1 (es) Composiciones de insulina de rápida acción
MX2020004084A (es) Agentes farmaceuticos como inhibidores del rsv para utilizar en combinacion.
DK3397631T3 (da) Substituerede 3-azabicyclo[3.1.0]hexaner som ketohexokinase-inhibitorer
CL2017000649A1 (es) Composiciones que contengan células de bacilo recombinantes y un insecticida
EA201891209A1 (ru) Модуляторы хемокиновых рецепторов
CL2017000660A1 (es) Composiciones que contengan células de bacilo recombinantes y un fungicida
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
MX2020005213A (es) Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos.
RS53818B1 (en) PIROLOBENZODIAZEPINI I NJIHOVI conjugated
BR112017005379A2 (pt) composições que compreendem células recombinantes de bacillus e um fungicida.
BR112017005504A2 (pt) composições que compreendem células recombinantes de bacillus e um inseticida.
FR3026308B1 (fr) Dispositif de diffusion d&#39;au moins un agent volatil
KR102430017B9 (ko) 헤테로고리 화합물 및 이를 이용한 유기 발광 소자
ES2974208T3 (es) Inhibidores de PDE4 que contienen boro
DK3717488T3 (da) Substituerede furanopyrimidinforbindelser som pde1-inhibitorer
CL2020000154A1 (es) Compuestos absorbentes
ES1216222Y (es) Composicion que comprende cenizas de cremacion
CL2015002389A1 (es) Composiciones herbicidas que contienen isoxabena y flufenaceto.
CL2015000610A1 (es) Derivados de isoxazolidina
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
FR3027985B1 (fr) Dispositif d&#39;amortissement des vibrations de type batteur inertiel
FR3024733B1 (fr) Agent epaississant pour systemes aqueux, formulations le contenant et utilisations.
NO20161136A1 (en) Compounds and compositions for biofilm prevention
FR3055020B3 (fr) Dispositif d&#39;evacuation segregative de deblais